| 发明名称 |
DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESISTANCE |
| 摘要 |
Provided in the present invention is a use of endostatin or a functional variant thereof in the preparation of a drug for treating alimentary obesity, non-alcoholic fatty liver disease, insulin resistance or glucose intolerance. In an embodiment of the invention, the functional variant can be YH-16, mES, mYH-16, m003, m007, mZ101, etc. |
| 申请公布号 |
WO2016070798(A1) |
申请公布日期 |
2016.05.12 |
| 申请号 |
WO2015CN93726 |
申请日期 |
2015.11.03 |
| 申请人 |
TSINGHUA UNIVERSITY;BEIJING PROTGEN LTD. |
发明人 |
LUO, YONGZHANG;WANG, HUI;LI, HUI;LU, XINAN;FU, YAN;ZHAN, SHUNLI;ZHOU, DAIFU |
| 分类号 |
A61K38/17;A61P1/16;A61P3/04;A61P5/50 |
主分类号 |
A61K38/17 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
